Drug Inspector Dismissed After Rs 4 Crore Cash Found in Sacks; Linked to Illegal Sale of Pharmacist Degrees

Patna: A drug inspector in Bihar has been dismissed from service following the discovery of Rs 4 crore in cash during a raid in 2022, along with evidence of extensive corruption, including the illegal sale of pharmacy degrees. The dismissal of Jitendra Kumar, who had been in service since 2012, was approved by the Nitish Kumar cabinet on Tuesday after a prolonged investigation.

The Vigilance Investigation Bureau raided Jitendra residence in the Sultanganj area of Patna on June 25, 2022. During the operation, five sacks filled with Rs 4,11,79,700 in cash were seized, along with about 1.5 kilograms of gold valued at over Rs 36.48 lakh and 3 kilograms of silver worth Rs 1.66 lakh. Officials also uncovered documents related to 27 properties, many of which were registered under his own name or in the names of close relatives including his wife, mother, brother-in-law, and brother.

The probe revealed that Jitendra held property across three states — Bihar, Uttar Pradesh, and Delhi — with assets in Patna, Jehanabad, Gaya, Bodh Gaya, Gautam Buddha Nagar, and Delhi. Alone, he personally owned 11 of these properties. Investigators estimate his total assets exceeded Rs 8 crore, representing a 160% disproportionate rise compared to his legal income of Rs 60 lakh during his decade-long service.
Further scrutiny of his bank records revealed deposits of Rs 16 lakh, and insurance policies worth Rs 19 lakh. Eight bank accounts and documents of 10 insurance schemes were recovered during the raid.

Sources within the investigation allege that Kumar was at the centre of a racket to sell fake pharmacist degrees through a private pharmacy college, where he was a board member. These degrees were sold for Rs 5 lakh each to individuals who did not meet qualification criteria, facilitating a large-scale fraud in pharmaceutical licensing.

Related Posts

  • Pharma
  • July 16, 2025
  • 278 views
Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Generic drugmakers Aurobindo Pharma, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir (CAB LA) for HIV treatment in 133 countries. This follows ViiV Healthcare, a company focused…

  • Pharma
  • July 16, 2025
  • 92 views
Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

The pharma sector will be in focus on July 16, after Donald Trump said that pharmaceuticals tariffs would be implemented soon. Shares of pharmaceutical companies traded flat on Wednesday, July…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates

Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates